Clinical trial

A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years…

NCT00158665 · Kaiser Permanente, Other · Completed

Key facts

NCT number NCT00158665
Title A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age
Official title A Comparison of One Versus Two Doses of Influenza Vaccine in Children Aged 5-8 Years of Age Receiving Influenza Vaccine for the First Time
Lead sponsor Kaiser Permanente, Other
Collaborators Centers for Disease Control and Prevention U.S. Fed
Status Completed
Study type Interventional
Conditions Influenza
Intervention type Biological
Interventions 2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine
Enrollment 280
Start date Aug 1, 2004
Primary completion Dec 1, 2004
Completion Dec 1, 2004
First posted Sep 12, 2005
Last update posted Oct 13, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies